ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2022
eQTL Set-Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma.
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
4 citing papers in PubMed, 8 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
70 authors at 20 institutions in 12 countries.
Xiaoyu WangDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.ORCID 0000-0002-4504-7799
Puya GharahkhaniQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0002-4203-5952
David M LevineDepartment of Biostatistics, University of Washington, School of Public Health, Seattle, Washington.ORCID 0000-0002-9292-570X
Rebecca C FitzgeraldMedical Research Council (MRC) Cancer Unit, Hutchison-MRC Research, Centre, University of Cambridge, Cambridge, UK.ORCID 0000-0002-3434-3568
Ines GockelDepartment of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany.ORCID 0000-0001-7423-713X
Douglas A CorleyDivision of Research, Kaiser Permanente Northern California, Oakland, California.ORCID 0000-0001-6132-5165
Harvey A RischDepartment of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut.ORCID 0000-0001-5337-3941
Leslie BernsteinDepartment of Population Sciences, Beckman Research Institute and City of Hope Comprehensive Cancer Center, Duarte, California.ORCID 0000-0002-7692-6518
Wong-Ho ChowDepartment of Epidemiology, MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0001-6076-0405
Lynn OnstadDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.ORCID 0000-0003-0039-7143
Nicholas J ShaheenDivision of Gastroenterology and Hepatology, University of North Carolina School of Medicine, University of North Carolina, Chapel Hill, North Carolina.ORCID 0000-0001-6602-5647
Jesper LagergrenDepartment of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0002-5143-5448
Anna H WuDepartment of Population and Public Health Sciences, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California.ORCID 0000-0003-0546-902X
Paul D P PharoahDepartment of Oncology, University of Cambridge, Cambridge, UK.ORCID 0000-0001-8494-732X
Geoffrey LiuPharmacogenomic Epidemiology, Ontario Cancer Institute, Toronto, Ontario, Canada.ORCID 0000-0002-2603-7296
Lesley A AndersonDepartment of Epidemiology and Public Health, Queen's University of Belfast, Royal Group of Hospitals, Northern Ireland.ORCID 0000-0002-1000-3649
Prasad G IyerDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-9822-1420
Marilie D GammonDepartment of Epidemiology, University of North Carolina, Chapel Hill, North Carolina.
Weimin YeDepartment of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0002-6859-4648
Hugh BarrDepartment of Upper GI Surgery, Gloucestershire Royal Hospital, Gloucester, UK.ORCID 0000-0002-2919-5660
Paul MoayyediFarncombe Family Digestive Health Research Institute, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.ORCID 0000-0002-3616-9292
Rebecca HarrisonDepartment of Pathology, Leicester Royal Infirmary, Leicester, UK.ORCID 0000-0002-6370-2005
R G Peter WatsonDepartment of Medicine, Institute of Clinical Science, Royal Victoria Hospital, Belfast, UK.ORCID 0000-0003-1703-1738
Stephen AttwoodDepartment of General Surgery, North Tyneside General Hospital, North Shields, UK.ORCID 0000-0002-5761-157X
Laura ChegwiddenUniversity of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.ORCID 0000-0001-5041-8163
Sharon B LoveCentre for Statistics in Medicine and Oxford Clinical Trials Research Unit, Oxford, UK.ORCID 0000-0002-6695-5390
David MacDonaldDepartment of Oral Biological and Medical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0002-6718-9296
John deCaesteckerDigestive Diseases Centre, University Hospitals of Leicester, Leicester, UK.ORCID 0000-0001-5526-8176
Hans PrenenOncology Department, University Hospital Antwerp, Edegem, Belgium.ORCID 0000-0001-8802-7352
Katja OttDepartment of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.ORCID 0000-0002-9979-2460
Susanne MoebusInstitute for Urban Public Health, University Hospitals, University of Duisburg-Essen, Essen, Germany.ORCID 0000-0002-0072-5410
Marino VeneritoDepartment of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital, Magdeburg, Germany.ORCID 0000-0001-8581-0974
Hauke LangDepartment of General, Visceral and Transplant Surgery, University Medical Center, University of Mainz, Mainz, Germany.ORCID 0000-0001-9303-2148
Christian GergesDepartment of Internal Medicine, Evangelisches Krankenhaus, Düsseldorf, Germany.ORCID 0000-0001-8271-1102
Josef WeismüllerGastroenterologische Gemeinschaftspraxis, Koblenz, Germany.ORCID 0000-0002-4232-5562
Matthias ReehDepartment of General, Visceral and Thoracic Surgery, Asklepios Harzklinik Goslar, Goslar, Germany.ORCID 0000-0001-9111-3905
Markus M NöthenInstitute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.ORCID 0000-0002-8770-2464
Jakob R IzbickiGeneral, Visceral and Thoracic Surgery Department and Clinic, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0001-6807-8224
Hendrik MannerDepartment of Internal Medicine II, Frankfurt Hoechst Hospital, Frankfurt, Germany.ORCID 0000-0003-0745-2336
Horst NeuhausDepartment of Internal Medicine, Evangelisches Krankenhaus, Düsseldorf, Germany.ORCID 0000-0001-6200-0688
Thomas RöschDepartment of Interdisciplinary Endoscopy, University Hospital Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0003-2270-2495
Anne C BöhmerInstitute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.ORCID 0000-0002-5716-786X
Arnulf H HölscherClinic for General, Visceral and Trauma Surgery, Contilia Center for Esophageal Diseases, Elisabeth Hospital Essen, Germany.ORCID 0000-0003-3400-6913
Mario AndersDepartment of Interdisciplinary Endoscopy, University Hospital Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0003-1452-924X
Oliver PechDepartment of Gastroenterology and Interventional Endoscopy, St. John of God Hospital, Regensburg, Germany.ORCID 0000-0002-8272-2079
Brigitte SchumacherDepartment of Internal Medicine, Evangelisches Krankenhaus, Düsseldorf, Germany.ORCID 0000-0001-7156-7141
Claudia SchmidtDepartment of General, Visceral and Cancer Surgery, University of Cologne, Cologne, Germany.ORCID 0000-0002-6720-867X
Thomas SchmidtDepartment of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.ORCID 0000-0002-7166-3675
Tania NoderDepartment of Interdisciplinary Endoscopy, University Hospital Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0003-4100-8810
Dietmar LorenzDepartment of General and Visceral Surgery, Sana Klinikum, Offenbach, Germany.ORCID 0000-0002-4541-590X
Michael ViethInstitute of Pathology, Friedrich-Alexander-University Erlangen-Nuremberg, Klinikum Bayreuth, Bayreuth, Germany.ORCID 0000-0002-4336-7721
Andrea MayDepartment of Gastroenterology, Oncology and Pneumology, Asklepios Paulinen Klinik, Wiesbaden, Germany.ORCID 0000-0002-1550-5074
Timo HessCenter for Human Genetics, University Hospital of Marburg, Marburg, Germany.ORCID 0000-0003-2778-4274
Nicole KreuserDepartment of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany.ORCID 0000-0002-0525-0426
Jessica BeckerInstitute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.ORCID 0000-0001-7141-2991
Ian TomlinsonEdinburgh Cancer Research Centre, IGMM, University of Edinburgh, Edinburgh, UK.ORCID 0000-0003-3037-1470
Claire PallesInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.ORCID 0000-0002-9670-2263
Janusz A JankowskiComprehensive Clinical Trials Unit, University College London, London, UK.ORCID 0000-0003-2130-9181
David C WhitemanCancer Control, QIMR Berghofer Medical Research Institute, Brisbane, Australia.ORCID 0000-0003-2563-9559
Stuart MacGregorQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0001-6731-8142
Johannes SchumacherCenter for Human Genetics, University Hospital of Marburg, Marburg, Germany.ORCID 0000-0001-9217-6457
Thomas L VaughanDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.ORCID 0000-0003-1537-0242
Matthew F BuasDepartment of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York.ORCID 0000-0002-8524-3428
James Y DaiDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.ORCID 0000-0001-6479-9286
Universität Hamburg · DEQIMR Berghofer Medical Research Institute · AUUniversity of Bonn · DEUniversity of Washington · USBayreuth Medical Center · DEElisabeth-Krankenhaus Essen · DEEvangelisches Krankenhaus Düsseldorf · DEFred Hutch Cancer Center · USHeidelberg University · DEPhilipps University of Marburg · DESana Klinikum Offenbach · DEUniversity Hospital Leipzig · DEUniversity of North Carolina at Chapel Hill · USUniversity of Ulster · GBAcoustic Metamaterials Group (China) · CNAntwerp University Hospital · BEAsklepios Fachklinikum Brandenburg · DEAsklepios Klinikum Harburg · DECancer Research UK Cambridge Center · GBCancer Research UK Clinical Trials Unit · GB
Funding
Statistical Genetics and Genomics for Epidemiologic ResearchR01CA222833 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI SUN, WEI · 2018 to 2022
$2.2M
High-Performance Compute Cluster for Comprehensive Cancer and Infectious Diseases ResearchS10OD028685 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BRADLEY, PHILIP · 2020 to 2020
$2.0M
Identification of gene-gene interactions in relation to risk of esophageal adenocarcinoma and Barrett's esophagusR03CA223731 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI BUAS, MATTHEW FRANK, YAN, LI · 2018 to 2019
$187k
Cancer Research UK 16942Cancer Research UK 4584NCI NIH HHS R01 CA222833NCI NIH HHS R03 CA223731NIH HHS S10 OD028685
6 · The paper itself
Abstract
backgroundOver 20 susceptibility single-nucleotide polymorphisms (SNP) have been identified for esophageal adenocarcinoma (EAC) and its precursor, Barrett esophagus (BE), explaining a small portion of heritability.
methodsUsing genetic data from 4,323 BE and 4,116 EAC patients aggregated by international consortia including the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON), we conducted a comprehensive transcriptome-wide association study (TWAS) for BE/EAC, leveraging Genotype Tissue Expression (GTEx) gene-expression data from six tissue types of plausible relevance to EAC etiology: mucosa and muscularis from the esophagus, gastroesophageal (GE) junction, stomach, whole blood, and visceral adipose. Two analytical approaches were taken: standard TWAS using the predicted gene expression from local expression quantitative trait loci (eQTL), and set-based SKAT association using selected eQTLs that predict the gene expression.
resultsAlthough the standard approach did not identify significant signals, the eQTL set-based approach identified eight novel associations, three of which were validated in independent external data (eQTL SNP sets for EXOC3, ZNF641, and HSP90AA1).
conclusionsThis study identified novel genetic susceptibility loci for EAC and BE using an eQTL set-based genetic association approach. IMPACT: This study expanded the pool of genetic susceptibility loci for EAC and BE, suggesting the potential of the eQTL set-based genetic association approach as an alternative method for TWAS analysis.
Indexed as
AdenocarcinomaBarrett EsophagusEsophageal NeoplasmsGenetic Predisposition to DiseaseHumansQuantitative Trait Loci
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
eQTL Set-Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma. · full record | OpenQuestion